A comparative study of tissue ω-6 and ω-3 polyunsaturated fatty acids (PUFA) in benign and malignant pathologic stage pT2a radical prostatectomy specimens

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 3, 2013, Pages 318-324

  Schumacher, Martin C ^a   Laven, Brett ^a   Petersson, Fredrik ^a   Cederholm, Tommy ^b   Onelöv, Eric ^c   Ekman, Peter ^a   Brendler, Charles ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

Arachidonic acid; Fatty acids; Prostate specimens; Radical prostatectomy

Indexed keywords

ADRENIC ACID; ARACHIDONIC ACID; DIHOMO GAMMA LINOLENIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ADULT; AGED; ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; COMPARATIVE STUDY; GAS LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TISSUE LEVEL;

ADULT; AGED; ARACHIDONIC ACID; CHROMATOGRAPHY, GAS; DIETARY FATS; ERUCIC ACIDS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; GAMMA-LINOLENIC ACID; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84875377381     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2011.01.014     Document Type: Article

References (25)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96.
2. De Marzo A.M., Platz E.A., Sutcliffe S., et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007, 7:256-269.
3. Chan J.M., Gann P.H., Giovannucci E.L. Role of diet in prostate cancer development and progression. J Clin Oncol 2005, 23:8152-8160.
4. Hodson L., Skeaff C.M., Fielding B.A. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 2008, 47:348-380.
5. Faas F.H., Dang A.Q., White J., et al. Decreased prostatic arachidonic acid in human prostatic carcinoma. BJU Int 2003, 92:551-554.
6. Rose D.P., Connolly J.M. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther 1999, 83:217-244.
7. Schumacher M.C., Laven B., Wolk A., et al. Do ω-3 fatty acids lower prostate cancer risk? A review of the literature. Curr Urol 2007, 1:2-10.
8. Fradet V., Cheng I., Casey G., et al. Dietary ω-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin Cancer Res 2009, 15:2559-2566.
9. Rose D.P., Connolly J.M. Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of 2 human prostate cancer cell lines. Prostate 1991, 18:243-254.
10. Wang Y., Corr J.G., Thaler H.T., et al. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst 1995, 87:1456-1462.
11. DiMarzo V. Arachidonic acid and eicosanoids as targets and effectors in second messenger interactions. Prostaglandins Leukotrienes Essent Fatty Acids 1995, 53:239-254.
12. Priante G., Bordin L., Musacchio E., et al. Fatty acids and cytokine mRNA expression in human osteoblastic cells: a specific effect of arachidonic acid. Clin Sci (Lond) 2002, 102:403-409.
13. Hughes-Fulford M., Tjandrawinata R.R., Li C.F., et al. Arachidonic acid, an ω-6 fatty acid, induces cytoplasmic phospholipase A2 in prostate carcinoma cells. Carcinogenesis 2005, 26:1520-1526.
14. Patel M.I., Singh J., Niknami M., et al. Cytosolic phospholipase A2-alpha: a potential therapeutic target for prostate cancer. Clin Cancer Res 2008, 14:8070-8079.
15. Yoshimura R., Sano H., Masuda C., et al. Expression of cyclooxygenase-2 in prostate carcinoma. Cancer 2000, 89:589-596.
16. Hanaka H., Pawelzik S.C., Johnsen J.I., et al. Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells. Proc Natl Acad Sci U S A 2009, 106:18757-18762.
17. Sporn M.B., Dunlop N.M., Newton D.L., et al. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 1976, 35:1332-1338.
18. Greenwald P. From carcinogenesis to clinical interventions for cancer prevention. Toxicology 2001, 166:37-45.
19. Rose D.P. Dietary fatty acids and cancer. Am J Clin Nutr 1997, 66:998S-1003S.
20. Aronson WJ, Barnard RJ, Freedland SJ, et al. Growth inhibitory effect of low fat diet on prostate cancer cells: results of a prospective, randomized dietary intervention trial in men with prostate cancer. J Urol;183:345-50.
21. Ghosh J., Myers C.E. Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc Natl Acad Sci U S A 1998, 95:13182-13187.
22. Simopoulos A.P. The Mediterranean diets: What is so special about the diet of Greece?. The scientific evidence. J Nutr 2001, 131:3065S-3073S.
23. Emken E.A., Adlof R.O., Gulley R.M. Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim Biophys Acta 1994, 1213:277-288.
24. Larsson S.C., Kumlin M., Ingelman-Sundberg M., et al. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 2004, 79:935-945.
25. Harizi H., Corcuff J.B., Gualde N. Arachidonic acid-derived eicosanoids: Roles in biology and immunopathology. Trends Mol Med 2008, 14:461-469.